Campbell & Co Investment Adviser’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
LG
Campbell & Co Investment Adviser's AMPH Position: Q2 2026 in Review
Campbell & Co Investment Adviser opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 23,211 shares worth $468K. The stake represents 0.02% of the portfolio and ranks #787 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in AMPH as recently as Q4 2025.
Campbell & Co Investment Adviser first reported a position in AMPH in Q1 2018 and has held it in 15 quarters since. The position peaked at $1.77M in Q4 2024. 82 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Campbell & Co Investment Adviser held 23,211 shares of Amphastar Pharmaceuticals worth $468K as of Q2 2026.
- Amphastar Pharmaceuticals was a new Campbell & Co Investment Adviser position in Q2 2026.
- Amphastar Pharmaceuticals made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #787 holding.
- Campbell & Co Investment Adviser first reported a position in Amphastar Pharmaceuticals in Q1 2018 and has held it in 15 quarters since.
- Campbell & Co Investment Adviser's Amphastar Pharmaceuticals position peaked at $1.77M in Q4 2024.
- 82 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.